HEADER HYDROLASE 20-AUG-18 6AHS TITLE MOUSE KALLIKREIN 7 IN COMPLEX WITH IMIDAZOLINYLINDOLE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERINE PROTEASE 6,STRATUM CORNEUM CHYMOTRYPTIC ENZYME, COMPND 5 THYMOPSIN; COMPND 6 EC: 3.4.21.117; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: KLK7, PRSS6, SCCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.SUGAWARA REVDAT 3 22-NOV-23 6AHS 1 REMARK REVDAT 2 23-JAN-19 6AHS 1 JRNL REVDAT 1 02-JAN-19 6AHS 0 JRNL AUTH H.MURAFUJI,T.MUTO,M.GOTO,S.IMAJO,H.SUGAWARA,Y.OYAMA, JRNL AUTH 2 Y.MINAMITSUJI,S.MIYAZAKI,K.MURAI,H.FUJIOKA JRNL TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP OF JRNL TITL 2 IMIDAZOLINYLINDOLE DERIVATIVES AS KALLIKREIN 7 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 29 334 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30522951 JRNL DOI 10.1016/J.BMCL.2018.11.011 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.MURAFUJI,H.SAKAI,M.GOTO,S.IMAJO,H.SUGAWARA,T.MUTO REMARK 1 TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF REMARK 1 TITL 2 1,3,6-TRISUBSTITUTED 1,4-DIAZEPANE-7-ONES AS NOVEL HUMAN REMARK 1 TITL 3 KALLIKREIN 7 INHIBITORS. REMARK 1 REF BIOORG. MED. CHEM. LETT. V. 27 5272 2017 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 29102227 REMARK 1 DOI 10.1016/J.BMCL.2017.10.030 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.MURAFUJI,H.SAKAI,M.GOTO,Y.OYAMA,S.IMAJO,H.SUGAWARA, REMARK 1 AUTH 2 T.TOMOO,T.MUTO REMARK 1 TITL STRUCTURE-BASED DRUG DESIGN OF 1,3,6-TRISUBSTITUTED REMARK 1 TITL 2 1,4-DIAZEPAN-7-ONES AS SELECTIVE HUMAN KALLIKREIN 7 REMARK 1 TITL 3 INHIBITORS. REMARK 1 REF BIOORG. MED. CHEM. LETT. V. 28 1371 2018 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 29550094 REMARK 1 DOI 10.1016/J.BMCL.2018.03.011 REMARK 1 REFERENCE 3 REMARK 1 AUTH H.MURAFUJI,H.SUGAWARA,M.GOTO,Y.OYAMA,H.SAKAI,S.IMAJO, REMARK 1 AUTH 2 T.TOMOO,T.MUTO REMARK 1 TITL STRUCTURE-BASED DRUG DESIGN TO OVERCOME SPECIES DIFFERENCES REMARK 1 TITL 2 IN KALLIKREIN 7 INHIBITION OF 1,3,6-TRISUBSTITUTED REMARK 1 TITL 3 1,4-DIAZEPAN-7-ONES. REMARK 1 REF BIOORG. MED. CHEM. V. 26 3639 2018 REMARK 1 REFN ESSN 1464-3391 REMARK 1 PMID 29884582 REMARK 1 DOI 10.1016/J.BMC.2018.05.044 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 24117 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1279 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1263 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.21 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 70 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1716 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : 0.61000 REMARK 3 B33 (A**2) : -1.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.022 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.023 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.055 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1797 ; 0.020 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1641 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2441 ; 1.591 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3844 ; 0.702 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 223 ; 6.850 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 65 ;37.468 ;25.077 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 312 ;15.685 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;26.538 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 266 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1942 ; 0.019 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 325 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 896 ; 1.742 ; 1.760 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 894 ; 1.719 ; 1.755 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1117 ; 2.262 ; 2.625 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1118 ; 2.265 ; 2.627 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 901 ; 3.146 ; 2.203 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 901 ; 3.127 ; 2.202 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1325 ; 4.669 ; 3.165 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2013 ; 6.410 ;22.788 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1996 ; 6.402 ;22.473 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 16 A 224 REMARK 3 ORIGIN FOR THE GROUP (A): -18.5818 26.1766 43.6988 REMARK 3 T TENSOR REMARK 3 T11: 0.1335 T22: 0.1232 REMARK 3 T33: 0.0045 T12: -0.0103 REMARK 3 T13: 0.0109 T23: -0.0163 REMARK 3 L TENSOR REMARK 3 L11: 0.4580 L22: 1.0834 REMARK 3 L33: 0.4958 L12: -0.0869 REMARK 3 L13: -0.1459 L23: 0.1368 REMARK 3 S TENSOR REMARK 3 S11: 0.0081 S12: -0.0407 S13: 0.0015 REMARK 3 S21: 0.0432 S22: -0.0352 S23: 0.0339 REMARK 3 S31: 0.0217 S32: -0.0097 S33: 0.0271 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6AHS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ. REMARK 100 THE DEPOSITION ID IS D_1300008796. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26249 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 5ZFH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, PEG 400, MAGNESIUM CHLORIDE, REMARK 280 TRIS/HCL, PH 8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.45350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.57800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.57800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.18025 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.57800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.57800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 24.72675 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.57800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.57800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 74.18025 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.57800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.57800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.72675 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 49.45350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 401 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 526 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 173 -124.42 59.56 REMARK 500 SER A 195 134.12 -34.90 REMARK 500 HIS A 245 -169.51 -127.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9YO A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TRS A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 304 DBREF 6AHS A 16 246 UNP Q91VE3 KLK7_MOUSE 26 249 SEQRES 1 A 224 ILE ILE ASP GLY TYR LYS CYS LYS GLU GLY SER HIS PRO SEQRES 2 A 224 TRP GLN VAL ALA LEU LEU LYS GLY ASN GLN LEU HIS CYS SEQRES 3 A 224 GLY GLY VAL LEU VAL ASP LYS TYR TRP VAL LEU THR ALA SEQRES 4 A 224 ALA HIS CYS LYS MET GLY GLN TYR GLN VAL GLN LEU GLY SEQRES 5 A 224 SER ASP LYS ILE GLY ASP GLN SER ALA GLN LYS ILE LYS SEQRES 6 A 224 ALA THR LYS SER PHE ARG HIS PRO GLY TYR SER THR LYS SEQRES 7 A 224 THR HIS VAL ASN ASP ILE MET LEU VAL ARG LEU ASP GLU SEQRES 8 A 224 PRO VAL LYS MET SER SER LYS VAL GLU ALA VAL GLN LEU SEQRES 9 A 224 PRO GLU HIS CYS GLU PRO PRO GLY THR SER CYS THR VAL SEQRES 10 A 224 SER GLY TRP GLY THR THR THR SER PRO ASP VAL THR PHE SEQRES 11 A 224 PRO SER ASP LEU MET CYS SER ASP VAL LYS LEU ILE SER SEQRES 12 A 224 SER ARG GLU CYS LYS LYS VAL TYR LYS ASP LEU LEU GLY SEQRES 13 A 224 LYS THR MET LEU CYS ALA GLY ILE PRO ASP SER LYS THR SEQRES 14 A 224 ASN THR CYS ASN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 A 224 ASN ASP THR LEU GLN GLY LEU VAL SER TRP GLY THR TYR SEQRES 16 A 224 PRO CYS GLY GLN PRO ASN ASP PRO GLY VAL TYR THR GLN SEQRES 17 A 224 VAL CYS LYS TYR LYS ARG TRP VAL MET GLU THR MET LYS SEQRES 18 A 224 THR HIS ARG HET 9YO A 301 26 HET TRS A 302 8 HET CL A 303 1 HET CL A 304 1 HETNAM 9YO 1-[(2-CHLOROPHENYL)SULFONYL]-5-METHYL-3-[(4R)-2-METHYL- HETNAM 2 9YO 4,5-DIHYDRO-1H-IMIDAZOL-4-YL]-1H-INDOLE HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM CL CHLORIDE ION HETSYN TRS TRIS BUFFER FORMUL 2 9YO C19 H18 CL N3 O2 S FORMUL 3 TRS C4 H12 N O3 1+ FORMUL 4 CL 2(CL 1-) FORMUL 6 HOH *142(H2 O) HELIX 1 AA1 ALA A 55 LYS A 59 5 5 HELIX 2 AA2 SER A 164 LYS A 173 1 10 HELIX 3 AA3 ASP A 174 LEU A 176 5 3 HELIX 4 AA4 TYR A 234 MET A 242 1 9 SHEET 1 AA1 8 TYR A 20 LYS A 21 0 SHEET 2 AA1 8 MET A 156 ILE A 163 -1 O CYS A 157 N TYR A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O CYS A 182 N ILE A 163 SHEET 4 AA1 8 GLY A 226 GLN A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 THR A 208 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 CYS A 201 -1 N LEU A 199 O GLY A 211 SHEET 7 AA1 8 SER A 135 GLY A 140 -1 N THR A 137 O VAL A 200 SHEET 8 AA1 8 MET A 156 ILE A 163 -1 O VAL A 160 N CYS A 136 SHEET 1 AA2 7 GLN A 30 LYS A 35 0 SHEET 2 AA2 7 GLN A 39 ASP A 48 -1 O CYS A 42 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 AA2 7 MET A 104 LEU A 108 -1 O VAL A 106 N VAL A 52 SHEET 5 AA2 7 GLN A 81 ARG A 90 -1 N PHE A 89 O LEU A 105 SHEET 6 AA2 7 TYR A 64 LEU A 68 -1 N VAL A 66 O ILE A 83 SHEET 7 AA2 7 GLN A 30 LYS A 35 -1 N LEU A 34 O GLN A 65 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.07 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 129 CYS A 232 1555 1555 2.08 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.07 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.08 CISPEP 1 SER A 146 PRO A 147 0 16.06 CISPEP 2 TYR A 218 PRO A 219 0 -0.98 SITE 1 AC1 12 HIS A 57 HIS A 99 ASP A 102 THR A 190 SITE 2 AC1 12 ASN A 192 SER A 195 SER A 214 TRP A 215 SITE 3 AC1 12 GLY A 216 THR A 217 TYR A 218 CYS A 220 SITE 1 AC2 9 CYS A 22 LYS A 23 GLU A 24 ASP A 71 SITE 2 AC2 9 LYS A 72 PRO A 92 ASP A 154 HOH A 402 SITE 3 AC2 9 HOH A 446 SITE 1 AC3 3 GLN A 76 ARG A 90 TYR A 94 SITE 1 AC4 4 LYS A 23 LYS A 59 SER A 88 ARG A 90 CRYST1 71.156 71.156 98.907 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014054 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014054 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010111 0.00000